SUMO2P7

Across TCGA pan-cancer cohorts, SUMO2P7 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SUMO2P7 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher SUMO2P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SUMO2P7 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

UVM, BLCA, and THYM are the cancer types where SUMO2P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.136	0.919	<.001	45	view →
BLCA	DFS	Tertile	IV	0.309	0.509	.003	42	view →
THYM	DFS	Tertile	II,III,IV	0.478	0.883	.007	38	view →
KIRC	DFS	Median	All	0.493	0.715	.002	32	view →
MESO	OS	Tertile	All	0.190	0.608	.002	27	view →
LUAD	OS	Quartile	II,III,IV	0.606	0.781	.006	26	view →
PAAD	DFS	Tertile	II,III,IV	0.294	0.480	.001	24	view →
COAD	OS	Tertile	III,IV	0.105	0.800	<.001	18	view →
CESC	DFS	Tertile	III,IV	0.560	0.776	.029	18	view →
HNSC	OS	Quartile	IV	0.541	0.287	.002	18	view →
SKCM	DFS	Tertile	IV	0.669	0.210	.016	15	view →
UCS	DFS	Quartile	III,IV	0.212	0.499	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SUMO2P7–UVM (OS)

Open the UVM breakdown →